Editorial: Frailty and Herbal Medicines- From Molecular Mechanisms to Clinical Efficacy

Editorial on the Research Topic
Frailty and Herbal Medicines- From Molecular Mechanisms to Clinical Efficacy

In East Asia, natural foods have been used as medicine and have played important roles in human health for centuries, based on the concept of “Eating healthy prevents and cures the disease” in Traditional Chinese medicine. Herbal medicines consist of various natural components obtained from the leaves, roots, and seeds of plants, combined with products from animal, fungal, and mineral origin. The use of herbal medicine has been recently gaining global interest (1). The World Health Organization (WHO) has proposed several guidelines for the use of herbal medicine (2–9), and the Traditional Medicine Strategy 2014–2023 is being undertaken (10). The WHO encourages the integration of traditional medicine into the next edition of the International Statistical Classification of Diseases and Related Health Problems (International Statistical Classification of Diseases and Related Health Problems-11, ICD-11) (11). However, herbal medicines are not fully accepted in clinical practice, and more evidence is required regarding the appropriate and safe usage of herbal medicines to be accepted as mainstream medicines. Traditional Chinese medicine has been part of human history for several thousands of years. The earliest extant medical book is called Huangdi Neijing (Canon of Internal Medicine, 770 BC~221 BC), while the earliest pharmacy monograph is known to be the Sheng Nong Bencao Jing (Sheng Nong Materia Medica, AD25~AD220) (12). Kampo medicine originates from Traditional Chinese medicine, while it was developed in Japan (13).

Herbal medicines in both Traditional Chinese medicine and Kampo medicine have been reported to have significantly beneficial effects, including fatigue- and pain-relief, reduction of infection in the respiratory tract, reduction of diarrhea, nausea, and vomiting, protection of the liver, as well as amelioration of the symptoms of cachexia. Recently, the number of clinical studies associated with frailty has increased; however, effective treatments have been only sporadically reported. Conversely, treatments using herbal medicines for frailty have been extensively published in Japanese journals, although such knowledge has not yet become global.

Frailty is characterized by unintentional weight loss, exhaustion, muscle weakness, slow walking speed, and low physical activity in elderly people, and is associated with an increased vulnerability to stressors and impairment of cognitive and emotional functions. Furthermore, various chronic diseases such as cancer, diabetes, respiratory disease, and psychosomatic disease worsen with the progress of frailty. These disorders associated with frailty have a significant rate of success when they are treated with Kampo medicine (Takayama et al.).

Kampo medicine is composed of various herbal products and is effective against a wide range of diseases. In Japan herbal medicine is prescribed following the theory of Kampo medicine, which is completely different from that of Western medicine. These differences of theory, therefore, make the performance of clinical studies in Western countries difficult. Researchers, who perform experiments using Kampo medicine, should continue providing evidence that Kampo medicine is effective against frailty and aging in order to spread the knowledge and facilitateits worldwide approval.

This Research Topic titled “Frailty and Herbal Medicines—From Molecular Mechanisms to Clinical Efficacy” was planned to provide scientific evidence focused on the mechanisms of herbal medicines in basic experiments. In this Research Topic, 30 articles are presented: 17 basic research studies; three clinical research studies, seven reviews; and three other articles (Tables 1–4). Various herbal medicines have been suggested as useful therapeutic options for frailty and frailty-associated symptoms. In the Kampo theory doctors and pharmacists analyze the syndromes and signs as well as the patient's history, and then the appropriate herbal medicine is selected. These syndromes are called “Sho” in the Kampo theory, which is categorized as three different indicators: Qi (well-being, energy, illness, and vigor), Blood, and Water (14). The arising abnormalities of Qi, Blood, and Water are considered the causes of diseases. The source of Qi is called “Jin.” The loss of Jin, “Jinkyo,” induces a deficiency of psychological and physical energy, which influences growth and reproductive functions in human beings. Jinkyo causes various symptoms such as loss of hair, gray hair, weariness, lumbago, osteoporosis, incontinence, cold legs, itching, and difficulty in hearing. These are all considered to be causes of frailty and aging in the Kampo theory. Hozai is an herbal medicine used to improve the loss of Qi and Blood. Ninjin'yoeito (NYT) is a Hozai formulation in Kampo medicine. NYT is composed of 12 crude drugs (Rehmannia root, Japanese angelica root, Atractylodes rhizome, Poria sclerotium, ginseng, cinnamon bark, polygala root, peony root, citrus unshiu peel, astragalus root, Glycyrrhiza, and Schisandra fruit). NYT has been proven effective against weakness, general malaise, fatigue, anorexia, night sweats, coldness, and anemia (ICD-10). These symptoms fall into categories such as the loss of Qi and Blood. NYT has been reported to include various active components, which have been reviewed by Uto et al. in this Research Topic. The efficacy and safety of NYT are also summarized in this topic. Similarly, the effects of many herbal medicines and their components except for Hozai are reported. Endogenous stem cells such as bone marrow, adipose cells, and umbilical cord-derived mesenchymal stem cells have multifactorial functions and secrete various factors. These characteristics may be similar to those of herbal medicines containing various active ingredients. The potential of mesenchymal stem cells for the therapy of frailty is described in this topic. A combination of stem cell therapy and herbal medicine may work well for the treatment of frailty.

TABLE 1

Table 1. Herbal medicines in basic studies of present Research Topics.

TABLE 2

Table 2. Herbal medicines in clinical studies of present Research Topics.

TABLE 3

Table 3. Reviews of present Research Topics.

TABLE 4

Table 4. Other in present Research Topics.

We hope that this Research Topic on the potential of herbal medicines will be informative. We believe that herbal medicines can become a mainstream treatment for frailty within a considerable period.

Author Contributions

The manuscript is written by KA. AI conceived and organized the structure of the editorial. AI, RT, JL, and NI contributed to the critical revision and approved the final manuscript for publication.

Conflict of Interest

KA and AI work in a laboratory funded by Kracie. RT works in the laboratory of Kracie.

The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

1. Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol. (2014) 4:177. doi: 10.3389/fphar.2013.00177

PubMed Abstract | CrossRef Full Text | Google Scholar

2. WHO Guidelines on Good Agricultural and Collection Practices (GACP) for Medicinal Plants. Geneva: World Health Organization (2003).

Google Scholar

3. WHO Guidelines on Assessing Quality of Herbal Medicines With Reference to Contaminants and Residues. Geneva: World Health Organization (2007).

Google Scholar

4. WHO guidelines for selecting marker substances of herbal origin for quality control of herbal medicines. In: WHO Expert Committee on Specification for Pharmaceutical Preparations: Fifty-First Report. Annex 1 (WHO Technical Report Series, No. 1003). Geneva: World Health Organization (2017).

Google Scholar

5. WHO good manufacturing practices (GMP): supplementary guidelines for the manufacture of herbal medicines. In: WHO Expert Committee on Specifications for Pharmaceutical Preparations: Fortieth Report. Annex 3 (WHO Technical Report Series, No. 937). Geneva: World Health Organization (2006).

Google Scholar

6. WHO Guidelines on Good Manufacturing Practices (GMP) for Herbal Medicines. Geneva: World Health Organization (2007).

Google Scholar

7. WHO good manufacturing practices (GMP): supplementary guidelines for the manufacture of herbal medicines. In: WHO Expert Committee on Specifications for Pharmaceutical Preparations: Fifty-Second Report. Annex 2 (WHO Technical Report Series, No. 1010). Geneva: World Health Organization (2018).

Google Scholar

8. Quality Control Methods for Herbal Materials. Geneva: World Health Organization (2011).

Google Scholar

9. WHO guidelines on good herbal processing practices for herbal medicines. In: WHO Expert Committee on Specifications for Pharmaceutical Preparations: Fifty-Second Report. Annex 1 (WHO Technical Report Series, No. 1010). Geneva: World Health Organization (2018).

Google Scholar

10. WHO Global Report on Traditional and Complementary Medicine 2019. Geneva: World Health Organization (2019).

Google Scholar

11. International Classification of Diseases (ICD). World Health Organization (2018). Available online at: http://www.who.int/classifications/icd/en/

Google Scholar

12. Cheung F. TCM: made in China. Nature. (2011) 480:S82–3. doi: 10.1038/480S82a

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Motoo Y, Seki T, Tsutani K. Traditional Japanese medicine, kampo: its history and current status. Chin J Integr Med. (2011) 17:85–7. doi: 10.1007/s11655-011-0653-y

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Yu F, Takahashi T, Moriya J, Kawaura K, Yamakawa J, Kusaka K, et al. Traditional Chinese medicine and Kampo: a review from the distant past for the future. J Int Med Res. (2006) 34:231–9. doi: 10.1177/147323000603400301

PubMed Abstract | CrossRef Full Text | Google Scholar